Spanish Español English English

Leader in biosolutions for pharmaceutical
and agro-food industry

News

    • 22 JUN 15
    Scientific milestones of Neuron Bio consolidate its strength in its 10th anniversary

    Scientific milestones of Neuron Bio consolidate its strength in its 10th anniversary

    Fernando Valdivieso, the president of Neuron Bio stated at the Shareholders’ Ordinary General Meeting during the previous press conference “scientific milestones achieved by Neuron Bio and its subsidiary Neol Bio have consolidated the Andalusia company as a reference in the biotech sector in Europe and we start to pave the way for USA”. The repurchase

    • 17 JUN 15
    Neuron Bio renews its corporate image

    Neuron Bio renews its corporate image

    Neuron Bio, a leading company in biotechnological solutions launches its new corporative image. The company, which marks its tenth anniversary this year, banks on a more modern image in line with its activity. Javier Burgos, CEO of Neuron Bio stated, “The renewal of our corporative image is part of the strategic plan presented by Neuron

    • 19 MAY 15
    Neol patents a new method for the production of a biolubricant oil

    Neol patents a new method for the production of a biolubricant oil

    • These oils are biodegradable and do not consume natural resources competing with food. Neol Bio, a subsidiary of Neuron Bio has presented a patent on a new procedure for the production of oil with high content of oleic acid based on the use of genetically improved variants of its microorganism Neoleum®. As in the

    • 25 APR 15
    Neuron Bio completes the capital increase succesfully

    Neuron Bio completes the capital increase succesfully

    Neuron Bio (NEU.MC), a biotech company quoting on the Spanish Alternative Market has completely fulfilled the capital increase launched in March. The capital increase has completely been subscribed arising € 1,942,500. During the additional period over 1,300,000 share applications have been received. The funds raised will be targeted to the development of the strategic plan of

MAB

  • Neuron Bio is listed on the Alternative Investment Market (MAB) in Spain

    Mercado alternativo bursatil
  • Use of cookies

    We use own and third-parties cookies to gather information to conduct statistical analysis on the use of our website in order to improve our services. If you continue browsing, we consider you accept the use of cookies. You can change these settings and obtain further information by reading this website.